Our research also found that low levels of IL-2 are effective signals for Treg cell activation and proliferation; therefore, low-dose IL-2 can be used to stimulate Treg cell proliferation and restore immune tolerance during treatment of autoimmune diseases such as RA. The gene discussed is IL2; the disease is rheumatoid arthritis.